4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001171000-16-000118
CIK 0001618561operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:48 PM ET
Size
7.9 KB
Accession
0001171000-16-000118
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2016-03-31$0.13/sh+500$63→ 6,320 total - Exercise/Conversion
Restricted Share Units
2016-03-31−500→ 2,500 totalExercise: $0.13From: 2016-03-31Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Holdings
- 1,500(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 3/31/16, and 500 Restricted Share Units shall vest and become convertible on each of 6/30/16, 9/30/16, 12/31/16, 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:48 PM ET
- Size
- 7.9 KB